Camp4 Therapeutics Corp. (CAMP)
NASDAQ · Healthcare
Camp4 Therapeutics Corp. EBITDA 2023–2025
Camp4 Therapeutics Corp. annual/quarterly ebitda history and growth rate from 2023 to 2026. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Camp4 Therapeutics Corp. ebitda for the quarter ending March 31, 2026 was -12.6 M, a 1.01% decrease year-over-year.
- Camp4 Therapeutics Corp. ebitda for the twelve months ending March 31, 2026 was -51.1 M, a 2.72% increase year-over-year.
- Camp4 Therapeutics Corp. annual ebitda for 2025 was -50.9 M, a 0.93% decrease from 2024.
- Camp4 Therapeutics Corp. annual ebitda for 2024 was -51.4 M, a 2.37% increase from 2023.
- Camp4 Therapeutics Corp. annual ebitda for 2023 was -50.2 M.
EBITDA
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Camp4 Therapeutics Corp. EBITDA — FAQ
Camp4 Therapeutics Corp. (CAMP) ebitda over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CAMP's ebitda history?
The chart and table above show Camp4 Therapeutics Corp.'s ebitda by year and by quarter, including the growth rate.